Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Intrastromal corneal inlays offer hope for hyperopia
Orlando-Synthetic keratophakia may offer a safe and effective method for refractive correction, according to the interim fol-low-up data from an FDA trial evaluating a hydrogel intrastromal corneal inlay (PermaVision, Anamed)-plus data on the procedure from outside the United States.
Related Videos
Related Content
